ORGANTRANS Controlled Organoids transplantation as enabler for regenerative medicine translation. ORGANTRANS project aims to develop a disruptive solution that enables the 3D printing of tissue-engineered constructs
About the project
Overview
Controlled Organoids transplantation as enabler for regenerative medicine translationRead more
Objectives
ORGANTRANS is a disruptive alternative to donor organs for patients with chronic end-stage liver diseasesFind out more
Competences
ORGANTRANS partner core competencesFind out more
Results
Publicly available deliverables, publications, press releases, downloads & gallery available for a view and downloadRead more
Partners
Meet the team
NEWS & EVENTS
One of the building blocks of the ORGANTRANS technology: Vascularization of 3D hydrogels in vitro by endothelial and mural cells
November 11, 2022
CSEM presented at the Biointerfaces International Conference 2022 | Zurich, Switzerland
September 15, 2022
32nd Annual Conference of the European Society for Biomaterials | Bordeaux, France
September 8, 2022
OrganTrans M32 extraordinary meeting | Leuven, Belgium
August 29, 2022
